Abstract:Background Folate metabolism plays an important role in DNA methylation and nucleic acid synthesis and thus may function as a regulatory factor in cancer development. Genome-wide association studies (GWASs) have identified some single-nucleotide polymorphisms (SNPs) associated with cutaneous melanoma-specific survival (CMSS), but no SNPs were found in genes involved in the folate metabolic pathway.Objectives To examine associations between SNPs in folate metabolic pathway genes and CMSS.Methods We comprehensively evaluated 2645 (422 genotyped and 2223 imputed) common SNPs in folate metabolic pathway genes from a published GWAS of 858 patients from The University of Texas MD Anderson Cancer Center and performed the validation in another GWAS of 409 patients from the Nurses' Health Study and Health Professionals Follow-up Study, in which 95/858 (11 center dot 1%) and 48/409 (11 center dot 7%) patients died of cutaneous melanoma, respectively.Results We identified two independent SNPs (MTHFD1 rs1950902 G>A and ALPL rs10917006 C>T) to be associated with CMSS in both datasets, and their meta-analysis yielded an allelic hazards ratio of 1 center dot 75 (95% confidence interval 1 center dot 32-2 center dot 32, P = 9 center dot 96 x 10(-5)) and 2 center dot 05 (1 center dot 39-3 center dot 01, P = 2 center dot 84 x 10(-4)), respectively. The genotype-phenotype correlation analyses provided additional support for the biological plausibility of these two variants' roles in tumour progression, suggesting that variation in SNP-related mRNA expression levels is likely to be the mechanism underlying the observed associations with CMSS.Conclusions Two possibly functional genetic variants, MTHFD1 rs1950902 and ALPL rs10917006, were likely to be independently or jointly associated with CMSS, which may add to personalized treatment in the future, once further validated.What is already known about this topic?Existing data show that survival rates vary among patients with melanoma with similar clinical characteristics; therefore, it is necessary to identify additional complementary biomarkers for melanoma-specific prognosis.A hypothesis-driven approach, by pooling the effects of single-nucleotide polymorphisms (SNPs) in a specific biological pathway as genetic risk scores, may provide a prognostic utility, and genetic variants of genes in folate metabolism have been reported to be associated with cancer risk.What does this study add?Two genetic variants in the folate metabolic pathway genes, MTHFD1 rs1950902 and ALPL rs10917006, are significantly associated with cutaneous melanoma-specific survival (CMSS).What is the translational message?The identification of genetic variants will make a risk-prediction model possible for CMSS.The SNPs in the folate metabolic pathway genes, once validated in larger studies, may be useful in the personalized management and treatment of patients with cutaneous melanoma.

Genetic Variants in the Integrin Signaling Pathway Genes Predict Cutaneous Melanoma Survival

187 Genetic Variants of the Ketone Metabolism Gene PDSS1 Predict Melanoma Survival

Novel Genetic Variants of ALG6 and GALNTL4 of the Glycosylation Pathway Predict Cutaneous Melanoma-Specific Survival

Genetic Variants In The Folate Metabolic Pathway Genes Predict Cutaneous Melanoma-Specific Survival

A Functional Synonymous Variant in PDGFRA is Associated with Better Survival in Acral Melanoma.

Association of genetic variants of TMEM135 and PEX5 in the peroxisome pathway with cutaneous melanoma-specific survival

Abstract 4843: Genetic Variants in Notch Signaling Pathway and Ovarian Cancer.

Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy.

Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.

Association of EGF Rs4444903 and XPD Rs13181 Polymorphisms with Cutaneous Melanoma in Caucasians.

Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma

Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer.

Novel Genetic Variants in HDAC2 and PPARGC1A of the CREB-binding Protein Pathway Predict Survival of Non-Small-cell Lung Cancer

Predictive Biomarkers and Personalized Medicine Genetic Variants in the PI 3 K / PTEN / AKT / mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor / Recurrence Risk and Response to Retinoid Chemoprevention

Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families.

Abstract PR-03: Genetic Variations in Microrna Biogenesis Genes As Predictors for Risk of Second Primary Tumor (SPT) And/or Recurrence in Patients with Early-Stage Head and Neck Cancer

Potentially Functional Genetic Variants of VAV2 and PSMA4 in the Immune‐activation Pathway and Non‐small Cell Lung Cancer Survival

Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.

Bioinformatical analysis identified significant genes in the PI3K-Akt signaling pathway relating with poor prognosis of skin cutaneous melanoma

Potentially Functional Genetic Variants of the Notch Signaling Pathway Genes Predict Survival of Chinese Patients with Esophageal Squamous Cell Carcinoma.

Abstract A3: MicroRNA-related Polymorphisms Are Associated with Clinical Outcomes in Early Stage Non-Small Cell Lung Cancer Patients